$GRYP
Gryphon Digital Mining Inc

2021 Q3 Form 10-Q Financial Statement

#000121390021042136 Filed on August 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $5.136M $4.907M $3.004M
YoY Change 38.27% 63.36% -17.03%
Cost Of Revenue $1.971M $1.914M $1.819M
YoY Change 13.3% 5.27% 68.39%
Gross Profit $3.164M $2.993M $1.185M
YoY Change 60.28% 152.52% -53.34%
Gross Profit Margin 61.61% 60.99% 39.45%
Selling, General & Admin $4.080M $6.202M $5.243M
YoY Change -10.68% 18.29% -60.1%
% of Gross Profit 128.94% 207.26% 442.43%
Research & Development $1.566M $1.527M $1.089M
YoY Change -10.94% 40.25% -59.52%
% of Gross Profit 49.51% 51.04% 91.89%
Depreciation & Amortization $1.238M $1.317M $1.320M
YoY Change 5.76% -0.23%
% of Gross Profit 39.14% 44.01% 111.39%
Operating Expenses $6.885M $9.044M $7.368M
YoY Change -8.17% 22.73% -12.18%
Operating Profit -$3.721M -$6.051M -$6.183M
YoY Change -32.64% -2.14% 5.7%
Interest Expense -$238.3K -$163.1K -$2.084K
YoY Change 6362.79% 7727.5% -110.42%
% of Operating Profit
Other Income/Expense, Net $2.167M -$46.16K $157.0K
YoY Change 41.01% -129.41%
Pretax Income -$1.553M -$6.097M -$6.026M
YoY Change -61.03% 1.17% 3.55%
Income Tax $4.300K $30.99K
% Of Pretax Income
Net Earnings -$1.553M -$6.105M -$5.313M
YoY Change -60.96% 14.92% -8.72%
Net Earnings / Revenue -30.25% -124.42% -176.87%
Basic Earnings Per Share
Diluted Earnings Per Share -$58.75K -$0.25 -$221.6K
COMMON SHARES
Basic Shares Outstanding 25.93M shares 24.14M shares
Diluted Shares Outstanding 1.322M shares 24.53M shares

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.609M $11.78M $24.16M
YoY Change -32.62% -51.25% 10.47%
Cash & Equivalents $9.600M $11.80M $24.16M
Short-Term Investments
Other Short-Term Assets $2.437M $2.673M $1.710M
YoY Change 23.1% 56.29% 58.33%
Inventory
Prepaid Expenses $2.194M $2.395M $1.215M
Receivables $1.648M $1.798M $1.862M
Other Receivables $265.2K $231.1K $0.00
Total Short-Term Assets $13.96M $16.48M $27.73M
YoY Change -26.66% -40.58% 14.59%
LONG-TERM ASSETS
Property, Plant & Equipment $52.32K $53.35K $131.1K
YoY Change -96.25% -59.3%
Goodwill $46.79M $46.79M $20.25M
YoY Change 0.62% 131.01%
Intangibles
YoY Change
Long-Term Investments $226.1K $226.1K $250.0K
YoY Change -5.79% -9.56%
Other Assets $41.93K
YoY Change
Total Long-Term Assets $60.55M $60.06M $30.80M
YoY Change -2.82% 95.0%
TOTAL ASSETS
Total Short-Term Assets $13.96M $16.48M $27.73M
Total Long-Term Assets $60.55M $60.06M $30.80M
Total Assets $74.51M $76.53M $58.53M
YoY Change -8.4% 30.76% 141.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.809M $1.126M $1.444M
YoY Change -69.85% -21.98% 9.59%
Accrued Expenses $3.377M $3.555M $3.420M
YoY Change 3.95% 584.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $2.000M $0.00
YoY Change -100.0%
Long-Term Debt Due $7.156M $6.140M
YoY Change 16.55%
Total Short-Term Liabilities $6.254M $13.37M $11.75M
YoY Change -65.51% 13.76% 381.27%
LONG-TERM LIABILITIES
Long-Term Debt $3.834M $1.201M $10.20M
YoY Change -30.04% -88.23%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.834M $1.201M $10.20M
YoY Change -30.04% -88.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.254M $13.37M $11.75M
Total Long-Term Liabilities $3.834M $1.201M $10.20M
Total Liabilities $10.09M $14.57M $23.01M
YoY Change -57.28% -36.68% 319.61%
SHAREHOLDERS EQUITY
Retained Earnings -$71.30M -$69.74M -$41.15M
YoY Change -35647962600.0% 69.46% 49.21%
Common Stock $132.8M $123.9M $71.90M
YoY Change 59.68% 72.26% 55.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $64.42M $61.96M $35.52M
YoY Change
Total Liabilities & Shareholders Equity $74.51M $76.53M $58.53M
YoY Change -8.4% 30.76% 141.84%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$1.553M -$6.105M -$5.313M
YoY Change -60.96% 14.92% -8.72%
Depreciation, Depletion And Amortization $1.238M $1.317M $1.320M
YoY Change 5.76% -0.23%
Cash From Operating Activities -$1.362M -$2.345M -$2.750M
YoY Change -67.42% -14.72% 2.23%
INVESTING ACTIVITIES
Capital Expenditures -$1.361M -$1.305M -$3.260M
YoY Change 112.72% -59.98%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$140.0K
YoY Change -100.0% -100.74%
Cash From Investing Activities -$1.361M -$1.305M -$3.400M
YoY Change -76.14% -61.63% -118.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 559.7K -3.850K 15.98M
YoY Change -4518.3% -100.02%
NET CHANGE
Cash From Operating Activities -1.362M -2.345M -2.750M
Cash From Investing Activities -1.361M -1.305M -3.400M
Cash From Financing Activities 559.7K -3.850K 15.98M
Net Change In Cash -2.164M -3.654M 9.830M
YoY Change -78.14% -137.17% -39.13%
FREE CASH FLOW
Cash From Operating Activities -$1.362M -$2.345M -$2.750M
Capital Expenditures -$1.361M -$1.305M -$3.260M
Free Cash Flow -$960.00 -$1.041M $510.0K
YoY Change -99.97% -304.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
760584 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-507089 USD
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Document Transition Report
DocumentTransitionReport
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Registrant Name
EntityRegistrantName
Akerna Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q2 us-gaap Liabilities
Liabilities
14572582 USD
CY2020Q4 us-gaap Liabilities
Liabilities
19946452 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
dei Entity Central Index Key
EntityCentralIndexKey
0001755953
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Shell Company
EntityShellCompany
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Entity File Number
EntityFileNumber
001-39096
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2242651
dei Entity Address Address Line1
EntityAddressAddressLine1
1550 Larimer Street
dei Entity Address Address Line2
EntityAddressAddressLine2
#246
dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80202
dei City Area Code
CityAreaCode
(888)
dei Local Phone Number
LocalPhoneNumber
932-6537
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
KERN
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25929693 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11778601 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17840640 USD
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
508261 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
500000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1797708 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1753547 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2395346 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2458727 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
16479916 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
22552914 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53354 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1193433 USD
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
226101 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
233664 USD
CY2021Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
5213267 USD
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3925739 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7772289 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7388795 USD
CY2021Q2 us-gaap Goodwill
Goodwill
46790018 USD
CY2020Q4 us-gaap Goodwill
Goodwill
41874527 USD
CY2021Q2 us-gaap Assets
Assets
76534945 USD
CY2020Q4 us-gaap Assets
Assets
77169072 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4681554 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3188576 USD
CY2021Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1180181 USD
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
843900 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
7155953 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
11707363 USD
CY2021Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
354247 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
311376 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
13371935 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16051215 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1200647 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3895237 USD
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2021Q2 kern Exchangable Preferred Stock
ExchangablePreferredStock
7951203 USD
CY2020Q4 kern Exchangable Preferred Stock
ExchangablePreferredStock
20405219 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25332439 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25332439 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19901248 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19901248 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
2533 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1990 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
123856649 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
94086433 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-105544 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-91497 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69742478 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57179525 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
61962363 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
57222620 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76534945 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77169072 USD
CY2021Q2 us-gaap Revenues
Revenues
4906887 USD
CY2020Q2 us-gaap Revenues
Revenues
3003638 USD
us-gaap Revenues
Revenues
8920911 USD
us-gaap Revenues
Revenues
6074184 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
1914380 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
1818565 USD
us-gaap Cost Of Revenue
CostOfRevenue
3368547 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
2992507 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
1185073 USD
us-gaap Gross Profit
GrossProfit
5552364 USD
us-gaap Gross Profit
GrossProfit
2859400 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1527258 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1088938 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2951358 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1963725 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1826143 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2117118 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3562058 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4157869 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4375981 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3126027 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6228943 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6583289 USD
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1314132 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1036378 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2367015 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1216607 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
9043514 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
7368461 USD
us-gaap Operating Expenses
OperatingExpenses
15109374 USD
us-gaap Operating Expenses
OperatingExpenses
13921490 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6051007 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6183388 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9557010 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-11062090 USD
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-163125 USD
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2084 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-937505 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
31438 USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-16405 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
766000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2007677 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
766000 USD
CY2021Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
133125 USD
CY2020Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-606958 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-42871 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-370041 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
243 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
243 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-124 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-46162 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
156958 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2987810 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
427273 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6097169 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6026430 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-12544820 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10634817 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4300 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30985 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10570 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30985 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3782 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3692 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7564 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3692 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-6061107 USD
us-gaap Profit Loss
ProfitLoss
-12562954 USD
us-gaap Profit Loss
ProfitLoss
-10669494 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-748584 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-849759 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-6105251 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-5312523 USD
us-gaap Net Income Loss
NetIncomeLoss
-12562954 USD
us-gaap Net Income Loss
NetIncomeLoss
-9819735 USD
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24530169 shares
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13166444 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12871648 shares
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6105251 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-6061107 USD
us-gaap Profit Loss
ProfitLoss
-12562954 USD
us-gaap Profit Loss
ProfitLoss
-10669494 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2183 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
USD
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.83
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
USD
CY2021Q1 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-230 USD
CY2021Q1 kern Stock Issued During Period Change In Fair Value Of Debt
StockIssuedDuringPeriodChangeInFairValueOfDebt
-13000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-6457702 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
59766045 USD
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
USD
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1729144 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19721235 USD
CY2020Q1 kern Common Stock Issued In Business Combination
CommonStockIssuedInBusinessCombination
17550000 USD
CY2020Q1 kern Noncontrolling Interests In Acquired Subsidiary
NoncontrollingInterestsInAcquiredSubsidiary
4863433 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
301948 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-4608387 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37828229 USD
CY2020Q2 kern Common Stock Issued In Business Combination
CommonStockIssuedInBusinessCombination
2531466 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1953 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
63000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-16000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
63000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6106068 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5998107 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12577001 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10606494 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57222620 USD
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
USD
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
8467500 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
333847 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
503379 USD
CY2021Q1 kern Stock Issued During Period Value Settlement Of Liabilities
StockIssuedDuringPeriodValueSettlementOfLiabilities
377325 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
USD
CY2021Q2 kern Shares Issued In Connection With Viridian Acquisition
SharesIssuedInConnectionWithViridianAcquisition
6002000 USD
CY2021Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
571242 USD
CY2021Q2 kern Stock Issued During Period Value Settlement Of Liabilities
StockIssuedDuringPeriodValueSettlementOfLiabilities
USD
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
USD
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
USD
CY2021Q2 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
2183 USD
CY2021Q2 kern Stock Issued During Period Change In Fair Value Of Debt
StockIssuedDuringPeriodChangeInFairValueOfDebt
-3000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6105251 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-61962363 USD
CY2020Q2 kern Noncontrolling Interests In Acquired Subsidiary
NoncontrollingInterestsInAcquiredSubsidiary
690578 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
458636 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
USD
CY2020Q2 kern Stock Issued During Period Change In Fair Value Of Debt
StockIssuedDuringPeriodChangeInFairValueOfDebt
63000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-6061107 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35510802 USD
us-gaap Profit Loss
ProfitLoss
-12562954 USD
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
7564 USD
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
3692 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
150294 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
370154 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1074621 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
USD
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1045180 USD
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
USD
kern Amortization Of Deferred Contract Costs
AmortizationOfDeferredContractCosts
242110 USD
kern Amortization Of Deferred Contract Costs
AmortizationOfDeferredContractCosts
USD
us-gaap Other Noncash Expense
OtherNoncashExpense
926968 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2367014 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1216607 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1177390 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
17344 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2007677 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
766000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-42871 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-370041 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
998000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-286118 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
400251 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
115934 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
120489 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1463669 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
975121 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-633052 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3715198 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8587734 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2004609 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1990584 USD
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
USD
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
156636 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-122675 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2004609 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2024545 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
333847 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
17164600 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1177390 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-333847 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15987210 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-124 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6053778 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5374931 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18340640 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19280897 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12286862 USD
us-gaap Interest Paid Net
InterestPaidNet
50854 USD
us-gaap Interest Paid Net
InterestPaidNet
USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
64963 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
51472 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
10196382 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
12453853 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
377325 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="border-left: none; border-right: none;"> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 1 - Description of Business</span></p> <p style="margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Description of Business</span></p> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">Akerna Corp., herein referred to as we, us our or Akerna, through our wholly owned subsidiaries MJ Freeway, LLC, or MJF, Trellis Solutions, Inc., or Trellis, Ample Organics, Inc, or Ample, Viridian Sciences, Inc, or Viridian, and solo sciences, inc, or Solo, provides enterprise software solutions that enable regulatory compliance and inventory management. Our proprietary, broad and growing suite of solutions are adaptable for industries in which interfacing with government regulatory agencies for compliance purposes is required, or where the tracking of organic materials from seed or plant to end products is desired. We develop products intended to assist states in monitoring licensed businesses’ compliance with state regulations and to help state-licensed businesses operate in compliance with such law. We provide our commercial software platform, MJ Platform<span style="font-size: 8pt;"><sup>®</sup></span>, Trellis<span style="font-size: 8pt;"><sup>®</sup></span> and Viridian Sciences® to state-licensed businesses, and our regulatory software platform, Leaf Data Systems<span style="font-size: 8pt;"><sup>®</sup></span>, to state government regulatory agencies. Through Solo,</span><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">we provide an innovative, next-generation solution for state and national governments to securely track product and waste throughout the supply chain with solo*TAG™</span><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">. The integration of MJ Platform<span style="font-size: 8pt;"><sup>®</sup></span> and solo*CODE™ </span><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">results in technology for consumers and brands that brings a consumer-facing mark designed to highlight the authenticity and signify transparency. </span></p> <p style="margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;"><span style="font-family: 'Times New Roman'; font-size: 10pt; text-indent: 0pt;"> </span><br/></p> <p style="margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">We consult with clients on a wide range of areas to help them successfully maintain compliance with state laws and regulations. We provide project-focused consulting services to clients who are initiating or expanding their cannabis business operations or are interested in data consulting engagements with respect to the legal cannabis industry. Our advisory engagements include service offerings focused on compliance requirement assessments, readiness and best practices, compliance monitoring systems, application processes, inspection readiness and business plan and compliance reviews. We typically provide our consulting services to clients in emerging markets that are seeking consultation on newly introduced licensing regimes and assistance with the regulatory compliant build-out of operations. </span></p> <p style="margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"><br/></span></p> <p style="text-align: justify; line-height: 13pt; margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;"><b><i><span style="font-size: 10pt; color: #000000;">Liquidity and Capital Resources</span></i></b><i><span style="font-size: 10.0pt;"/></i></p> <p style="text-align: justify; line-height: 13pt; margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 10.0pt;"> </span></p> <p style="text-align: justify; text-indent: 33.35pt; margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 10.0pt;"><span style="font-family: 'times new roman', times;">Since our inception, we have incurred recurring operating losses, used cash from operations, and relied on capital raising transactions to continue ongoing operations. During the three and six months ended June 30, 2021, we incurred a loss from operations of $6.1 million and $9.6 million, respectively, and for the six months ended June 30, 2021, we used cash in operations of $3.7 million. As of June 30, 2021, we had cash of $11.8 million, excluding restricted cash, and working capital of $3.1 million. During the six months ended June 30, 2021, the Company incurred a number of one-time, non-recurring expenses of approximately $2.7 million. These expenses include business combination and merger related costs, restructuring charges, and other non-recurring charges. After considering all available evidence, we determined that, due to our current positive working capital, our ability to repay our senior secured convertible note with shares of our common stock, and our initiatives to reduce operating expenditures, that we have sufficient working capital to sustain operations for a period of at least twelve months from the date that our June 30, 2021 financial statements were issued.</span></span></p> <p style="text-align: justify; line-height: 13pt; margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 10.0pt;"> </span></p> <p style="margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;">In the event the Company requires additional liquidity, the Company believes it can further reduce or defer expenses. More specifically, the Company could implement certain discretionary cost reduction initiatives relating to our spending on employee travel and entertainment, consulting costs and marketing expenses, negotiate deferred salary arrangements, furlough employees or reduce headcount or negotiate extensions of payments of rent and utilities. The Company also believes it has access to capital through future debt or equity offerings and could be successful in renegotiating the maturity dates or conversion option relating to its current outstanding notes payable, although no assurance can be provided that we would be successful in these efforts. Further, the potential continues to exist that our $2 million PPP loan could be forgiven. Management will continue to evaluate our liquidity and capital resources.</span><br/></span></p> <p style="margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;"><br/></span></span></p> <p style="margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;">On July 23, 2021, we entered into an Equity Distribution Agreement with Oppenheimer &amp; Co. Inc. and A.G.P./Alliance Global Partners. Pursuant to the terms of the Agreement, we may offer and sell from time to time, up to $25 million of shares of our common stock. While no assurance can be provided that we will be able to raise capital under such program, we intend to use the net proceeds from the sale of our shares of common stock, if any, for general corporate purposes, including working capital, marketing, product development, capital expenditures and merger and acquisition activities.<br/></span></span></p> </div>
CY2021Q2 kern Loss From Operations
LossFromOperations
6100000 USD
kern Loss From Operations
LossFromOperations
9600000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3700000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11800000 USD
CY2021Q2 kern Working Capital
WorkingCapital
3100000 USD
kern Non Recurring Expenses
NonRecurringExpenses
2700000 USD
CY2021Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
2000000 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin: 0cm; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif;"><span style="font-family: 'times new roman', times;"><b><i><span style="font-size: 10.0pt;">Use of Estimates</span></i></b></span></p> <p style="margin: 0cm; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif;"><span style="font-family: 'times new roman', times; line-height: inherit;"><b><i><span style="font-size: 10pt; line-height: inherit;"><br/></span></i></b></span></p> <p style="margin: 0pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt;"><span style="font-family: 'times new roman', times; line-height: inherit;"><b><i><span style="font-size: 10pt; line-height: inherit;"/></i></b></span><span style="font-size: 10pt; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;">The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the financial statements and accompanying notes thereto. <span style="color: #000000; line-height: inherit;">We base our estimates on assumptions that we believe to be reasonable under the circumstances, the results of which form a basis for making judgments about the carrying value of assets and liabilities that are not readily available from other sources.</span> Actual results could differ materially from those estimates <span style="color: #000000; line-height: inherit;">under different assumptions or conditions; however, we believe that our estimates are reasonable</span>.  </span></span></p>
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1126483 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin: 0cm; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.3;"><span style="font-family: 'times new roman', times; line-height: inherit;"><b><i><span style="font-size: 10pt; line-height: inherit;">Concentrations of Credit Risk</span></i></b></span></p> <p style="margin: 0cm; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.3;"><span style="font-size: 10pt; color: #000000; font-family: 'times new roman', times; line-height: inherit;"><br/></span></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3; text-align: justify;"><span style="font-size: 10pt; color: #000000; font-family: 'times new roman', times; line-height: inherit;">We grant credit in the normal course of business to customers in the United States. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk. </span></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3;"><span style="font-size: 10pt; color: #000000; line-height: inherit;"><span style="font-family: 'times new roman', times; background-color: #ffff00; line-height: inherit;"><br/></span></span></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3; text-align: justify;"><span style="font-size: 10pt; color: #000000; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;">During the six months ended June 30, 2021 and 2020, one government client accounted for 11% and 26% of total revenues, respectively. During the three<span style="border-right: none; border-left: none;"><span style="border-left: none; border-right: none;"> months ended</span> June 30, 2021</span> and 2020, <span style="border-left: none; border-right: none;">one</span> government client accounted for <span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: inherit;">10<span style="line-height: inherit;">%</span></span><span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: inherit;"> and 28% of total revenues, respectively. As of June 30, 2021 and December 31, 2020, </span>two government clients accounted for a total of <span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: inherit;">37</span>% and 36% of net accounts receivable, respectively. </span></span></p>
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
513610 USD
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
461594 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
333709 USD
CY2021Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
245759 USD
CY2020Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
216367 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin: 0cm; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.3;"><span style="font-family: 'times new roman', times; line-height: inherit;"><b><i><span style="font-size: 10pt; line-height: inherit;">Reclassifications and Revisions</span></i></b><span style="font-size: 10pt; line-height: inherit;"/></span></p> <p style="margin: 0pt; text-align: justify; line-height: 1.3; font-size: 7pt;"><span style="font-family: 'Times New Roman'; font-size: 7pt; line-height: inherit;"> </span></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.3; text-indent: 33.3333pt; text-align: justify;"><span style="font-size: 10pt; font-family: 'times new roman', times; line-height: inherit;">Certain prior year financial statement amounts have been reclassified for consistency with the current year presentation.</span></p>
CY2021Q2 us-gaap Noncurrent Assets
NoncurrentAssets
18478000 USD
CY2020Q4 us-gaap Noncurrent Assets
NoncurrentAssets
15068 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8921000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6074000 USD
kern Adjustedforadoption
Adjustedforadoption
8921000 USD
kern Adjustedforadoption
Adjustedforadoption
6074000 USD
CY2021Q2 kern Unsatisfiedperformanceobligations
Unsatisfiedperformanceobligations
5.7 USD
CY2021Q2 kern Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
2900000 USD
CY2020Q4 us-gaap Deferred Revenue
DeferredRevenue
844000 USD
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
3362000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
3026000 USD
CY2020Q4 kern Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
8900000 USD
CY2020 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
400000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
228000 USD
us-gaap Additions To Contract Holders Funds
AdditionsToContractHoldersFunds
217000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
203000 USD
CY2021Q2 kern Reduction Of Contingent Consideraiton
ReductionOfContingentConsideraiton
6000000.0 USD
CY2021Q2 kern Stock Consideration In Cash
StockConsiderationInCash
1000000.0 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
9929000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-12561000 USD
CY2021Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
5506 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
11362000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-13431000 USD
kern Preferred Stock Liquidation Description
PreferredStockLiquidationDescription
special voting preferred stock has a par value of $0.0001 per share and a preference in liquidation of $<span>1.00</span>.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
0.0001
CY2021Q2 kern Prepaid Expenses Software And Technology
PrepaidExpensesSoftwareAndTechnology
570777 USD
CY2020Q4 kern Prepaid Expenses Software And Technology
PrepaidExpensesSoftwareAndTechnology
480651 USD
CY2021Q2 kern Prepaid Professional Fees
PrepaidProfessionalFees
741581 USD
CY2020Q4 kern Prepaid Professional Fees
PrepaidProfessionalFees
826195 USD
CY2021Q2 us-gaap Prepaid Insurance
PrepaidInsurance
548023 USD
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
243222 USD
CY2021Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
202556 USD
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
227718 USD
CY2021Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
231095 USD
CY2020Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
612446 USD
CY2021Q2 us-gaap Other Assets
OtherAssets
101313 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
68495 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2395345 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2458727 USD
CY2019Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
14960000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
9269677 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
USD
CY2021Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
216301 USD
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
311379 USD
CY2021Q2 kern Accrued Contractors
AccruedContractors
596921 USD
CY2020Q4 kern Accrued Contractors
AccruedContractors
1281857 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2034496 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
531654 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4681554 USD
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3188576 USD
CY2020Q2 us-gaap Convertible Debt
ConvertibleDebt
17000000.0 USD
CY2020Q2 kern Debt Purchase Price
DebtPurchasePrice
15000000.0 USD
CY2021Q1 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
7705000 USD
CY2020Q1 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
14960000 USD
CY2021Q2 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
1572405 USD
CY2020Q2 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
USD
CY2021Q2 kern Changes In Fair Value Reported In Statements Of Operations
ChangesInFairValueReportedInStatementsOfOperations
16405 USD
CY2020Q2 kern Changes In Fair Value Reported In Statements Of Operations
ChangesInFairValueReportedInStatementsOfOperations
-766000 USD
CY2021Q2 kern Change In Fair Value Reported In Other Comprehensive Income
ChangeInFairValueReportedInOtherComprehensiveIncome
3000 USD
CY2020Q2 kern Change In Fair Value Reported In Other Comprehensive Income
ChangeInFairValueReportedInOtherComprehensiveIncome
-63000 USD
CY2021Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
6152000 USD
CY2020Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
14131000 USD
CY2020Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
13398000 USD
kern Changes In Fair Value Reported In Statements Of Operations
ChangesInFairValueReportedInStatementsOfOperations
2007677 USD
kern Changes In Fair Value Reported In Statements Of Operations
ChangesInFairValueReportedInStatementsOfOperations
-766000 USD
kern Change In Fair Value Reported In Other Comprehensive Income
ChangeInFairValueReportedInOtherComprehensiveIncome
16000 USD
kern Change In Fair Value Reported In Other Comprehensive Income
ChangeInFairValueReportedInOtherComprehensiveIncome
-63000 USD
CY2021Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
6152000 USD
CY2020Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
14131000 USD
CY2020Q4 kern Recovery For Unpaid Invoices
RecoveryForUnpaidInvoices
1070000.00 USD
CY2020Q4 kern Litigation Of Business Description
LitigationOfBusinessDescription
TechMagic USA LLC purports to have provided to Solo regarding development of mobile software applications for MJF and Solo between March and November 2020 totaling approximately $787,000. The suit seeks continued fees under the Master Services Agreement through the end of January 2021. Akerna provided a notice of termination of the Master Services Agreement on November 23, 2020 and the parties dispute the effective date of the termination. Solo disputes the validity of the invoices, in whole or in part, and intends to defend the suit vigorously. Mr. Ashesh Shah, formerly the president of Solo and currently the holder of <span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">5</span></span><span style="border-left: none; border-right: none; line-height: inherit;">.<span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">1</span></span></span></span></span></span>% of our issued and outstanding shares of common stock is, to our knowledge, the founder and one of the principal managers of TechMagic USA LLC. As of June 30, 2021 and December 31, 2020, we recognized a loss contingency of $0.6 million.
kern Development Of Software Application
DevelopmentOfSoftwareApplication
787000 USD
kern Termination Expense
TerminationExpense
1300000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9645604 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8151424 shares

Files In Submission

Name View Source Status
0001213900-21-042136-index-headers.html Edgar Link pending
0001213900-21-042136-index.html Edgar Link pending
0001213900-21-042136.txt Edgar Link pending
0001213900-21-042136-xbrl.zip Edgar Link pending
ex311_1.htm Edgar Link pending
ex312_2.htm Edgar Link pending
ex321_3.htm Edgar Link pending
ex322_4.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kern-20210630.htm Edgar Link pending
kern-20210630.xsd Edgar Link pending
kern-20210630_cal.xml Edgar Link unprocessable
kern-20210630_def.xml Edgar Link unprocessable
kern-20210630_htm.xml Edgar Link completed
kern-20210630_lab.xml Edgar Link unprocessable
kern-20210630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending